BlackRock Portfolio holdings
BlackRock, Inc., founded in 1988 by Larry Fink and a group of partners, is the world’s largest asset management firm, headquartered in New York City. Initially starting as a risk management and fixed-income institutional asset manager, it has grown to manage over $10 trillion in assets through a combination of organic growth and strategic acquisitions, such as its 2009 purchase of Barclays Global Investors. BlackRock is known for its extensive range of investment products, including mutual funds, ETFs (notably under the iShares brand), and alternative investments, serving clients ranging from individuals to governments.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Moderna
MRNA
|
+$2.76B |
| 2 |
Analog Devices
ADI
|
+$2.38B |
| 3 |
Amazon
AMZN
|
+$2.01B |
| 4 |
Tesla
TSLA
|
+$1.68B |
| 5 |
Snowflake
SNOW
|
+$1.58B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$3.21B |
| 2 |
MXIM
Maxim Integrated Products
MXIM
|
+$2.54B |
| 3 |
Vanguard Short-Term Corporate Bond ETF
VCSH
|
+$1.28B |
| 4 |
Alibaba
BABA
|
+$1.25B |
| 5 |
WORK
Slack Technologies, Inc.
WORK
|
+$1.15B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Healthcare | 13.81% |
| 3 | Financials | 13.25% |
| 4 | Consumer Discretionary | 11.13% |
| 5 | Communication Services | 8.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AMPE
3251
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $20.4M | ﹤0.01% |
40,954
+485
| +1% | +$225K |
|
3252
CRH
CRH
$65.2B
| $20.4M | ﹤0.01% |
436,008
+24,418
| +6% | +$1.24M |
|
|
EMWP
3253
DELISTED
Eros Media World PLC
EMWP
| $20.3M | ﹤0.01% |
1,106,036
+1,037
| +0.1% | +$19.8K |
|
|
OLO
3254
DELISTED
Olo Inc
OLO
| $20.3M | ﹤0.01% |
677,211
-137,789
| -17% | -$4.92M |
|
|
FUV
3255
DELISTED
Arcimoto, Inc. Common Stock
FUV
| $20.3M | ﹤0.01% |
88,717
+761
| +0.9% | +$207K |
|
3256
Mid Penn Bancorp
MPB
$969M
| $20.3M | ﹤0.01% |
735,586
+12,962
| +2% | +$346K |
|
3257
Rush Enterprises Class B
RUSHB
$9.18B
| $20.2M | ﹤0.01% |
662,964
+5,314
| +0.8% | +$150K |
|
3258
Centrus Energy
LEU
$3.83B
| $20.2M | ﹤0.01% |
522,955
+3,886
| +0.7% | +$108K |
|
3259
CALL
Energy Transfer Partners
ET
$71.5B
| $20.2M | ﹤0.01% |
+2,109,200
| New | +$20.2M |
|
3260
Donegal Group Class A
DGICA
$692M
| $20.2M | ﹤0.01% |
1,393,111
-9,704
| -0.7% | -$146K |
|
|
TECX
3261
Tectonic Therapeutic
TECX
$720M
| $20.2M | ﹤0.01% |
301,205
+6,642
| +2% | +$545K |
|
3262
Utah Medical Products
UTMD
$230M
| $20.1M | ﹤0.01% |
216,259
-8,586
| -4% | -$758K |
|
3263
SoundThinking
SSTI
$107M
| $20.1M | ﹤0.01% |
551,543
-5,770
| -1% | -$242K |
|
3264
Primis Financial Corp
FRST
$411M
| $20.1M | ﹤0.01% |
1,386,930
-134,949
| -9% | -$2.02M |
|
3265
iShares International Select Dividend ETF
IDV
$8.53B
| $20M | ﹤0.01% |
657,479
+319,036
| +94% | +$10.2M |
|
|
KINZU
3266
DELISTED
KINS Technology Group Inc. Unit
KINZU
| $20M | ﹤0.01% |
2,000,000
| – | – |
|
3267
Aurinia Pharmaceuticals
AUPH
$2.02B
| $20M | ﹤0.01% |
902,663
+291,672
| +48% | +$4.63M |
|
3268
Nomura Holdings
NMR
$29B
| $19.9M | ﹤0.01% |
4,034,944
+173,811
| +5% | +$868K |
|
3269
Quantum Corp
QMCO
$973M
| $19.9M | ﹤0.01% |
192,135
+18
| +0% | +$2.12K |
|
3270
Golub Capital BDC
GBDC
$3.48B
| $19.9M | ﹤0.01% |
1,258,197
+249,762
| +25% | +$3.92M |
|
|
ITIC
3271
Investors Title Co
ITIC
$530M
| $19.9M | ﹤0.01% |
108,843
-4,485
| -4% | -$808K |
|
3272
Commercial Vehicle Group
CVGI
$128M
| $19.9M | ﹤0.01% |
2,100,408
+1,939
| +0.1% | +$18.3K |
|
3273
VirnetX Holding Corp
VHC
$65.8M
| $19.9M | ﹤0.01% |
253,427
+5,442
| +2% | +$445K |
|
|
CMAX
3274
DELISTED
CareMax, Inc. Class A Common Stock
CMAX
| $19.8M | ﹤0.01% |
68,274
+26,755
| +64% | +$7.87M |
|
|
GOOS
3275
Canada Goose Holdings
GOOS
$850M
| $19.7M | ﹤0.01% |
553,616
-57,276
| -9% | -$2.28M |
|
Similar funds
BlackRock's Q3 2021 Portfolio in Review
As of Q3 2021, BlackRock held 5,803 positions worth $3.57T, down 0.58% from $3.59T the previous quarter. Its ten largest holdings account for 19% of the portfolio.
BlackRock's Q3 2021 filing shows 283 new, 2,199 increased, 2,669 reduced and 164 closed positions. Its largest new stake was GXO Logistics: 8,566,775 shares worth $672M. The largest sale was Alexion Pharmaceuticals, an estimated $3.21B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 23% a quarter earlier, followed by Healthcare and Financials.
- BlackRock's largest Q3 2021 buy was GXO Logistics: 8,566,775 shares worth $672M.
- BlackRock added most to Moderna in Q3 2021, an estimated $2.76B increase.
- BlackRock's biggest Q3 2021 reduction was Vanguard Short-Term Corporate Bond ETF, cutting an estimated $1.28B.
- BlackRock fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $3.21B.
- BlackRock's ten largest holdings make up 19% of its $3.57T portfolio in Q3 2021.
- BlackRock opened 283 new positions and closed 164 in Q3 2021.
- BlackRock's portfolio value fell 0.58% quarter-over-quarter to $3.57T.
Based on BlackRock's 13F filing for Q3 2021, filed 9 Nov 2021.